EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 121 filers reported holding EPIZYME INC in Q1 2022. The put-call ratio across all filers is 4.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $23,000 | +76.9% | 15,555 | +40.7% | 0.00% | – |
| Q1 2022 | $13,000 | -53.6% | 11,055 | 0.0% | 0.00% | – |
| Q4 2021 | $28,000 | -93.8% | 11,055 | -87.4% | 0.00% | -100.0% |
| Q3 2021 | $450,000 | -57.8% | 87,800 | -31.6% | 0.01% | -60.0% |
| Q2 2021 | $1,066,000 | -3.1% | 128,298 | +1.6% | 0.02% | -11.8% |
| Q1 2021 | $1,100,000 | -28.3% | 126,298 | -10.6% | 0.02% | -32.0% |
| Q4 2020 | $1,535,000 | +1.2% | 141,319 | +11.1% | 0.02% | -10.7% |
| Q3 2020 | $1,517,000 | – | 127,155 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
| Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
| Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
| MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
| Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
| Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
| Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
| Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
| Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
| Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |